Competitive Grants Program
Pfizer supports the global healthcare community’s independent initiatives (e.g., research, quality improvement or education) to improve patient outcomes in areas of unmet medical need that are aligned with Pfizer’s medical and/or scientific strategies.
Pfizer’s competitive grant program involves a publicly posted Request for Proposal (RFP) that provides detail regarding a specific area of interest and sets timelines for review and approval. Organizations are invited to submit an application addressing the specific gaps in research, practice or care as outlined in the specific RFP. The grant requester (and ultimately the grantee) is responsible for the design, implementation, sponsorship, and conduct of the independent initiative supported by the grant, including compliance with any regulatory requirements.
Sign up to receive all grant announcements, including Request for Proposal (RFP) postings.
Sign Up for Alerts DetailsTitle Grant Type Focus Area Country Application Due Date Epidemiology and surveillance of Gram-negative infections caused by carbapenemase-producing organisms (CPOs) in the UKRelease Date:Research Internal Medicine United Kingdom Advancing Care for Patients with Advanced ALK+ Non-Small Cell Lung Cancer (NSCLC)Education Oncology All Quality Improvement Solutions for the Diagnosis and Management of Migraine and Headache DisordersQuality Improvement Internal Medicine Canada, USA Shared Decision Making in Hemophilia Patient CareRelease Date:Quality Improvement Rare Disease China Real-World Atopic Dermatitis: Italian Insights GrantRelease Date:Research Inflammation & Immunology Italy Evolving Treatment Options in First-Line Metastatic Urothelial Carcinoma (mUC) and Muscle Invasive Bladder Cancer (MIBC)Education Oncology All Optimizing Care for patients with Muscle Invasive Bladder Cancer (MIBC)Release Date:Quality Improvement Oncology Canada Optimizing HRRm Testing and Workflow Integration in mCSPCRelease Date:Quality Improvement, Research Oncology Canada Driving Timely Biomarker Testing to Optimize Treatment Decisions for Colorectal Cancer Patients Across CanadaRelease Date:Partner: Colorectal Cancer Canada (CCC)Quality Improvement, Research Oncology Canada Antimicrobial Stewardship —Treatment optimization under antibiotics appropriate use policy in ChinaRelease Date:Research Inflammation & Immunology China Title Grant Type Focus Area Country Application Due Date NSCLC Biomarker TestingRelease Date:Quality Improvement Oncology Andorra, Austria, Belgium, Canada, Denmark, Finland, France, Germany, Greece, Iceland, Ireland, Italy, Liechtenstein, Luxembourg, Malta, Monaco, Netherlands, Norway, Portugal, San Marino, Spain, Sweden, Switzerland, USA, United Kingdom Development of Talazoparib for Prostate CancerRelease Date:Partner: National Comprehensive Cancer NetworkResearch Oncology USA Approaches to Smoking Cessation CounselingRelease Date:Education Internal Medicine Australia, India, Japan, New Zealand, Singapore, Taiwan Burden of Community Acquired PneumoniaRelease Date:Research Vaccines USA Closing Knowledge Gaps in Moderate-to-Severe Alopecia AreataRelease Date:Education Inflammation & Immunology USA Progress in Androgen Deprivation Therapy (ADT) in Advanced Prostate CancerEducation Oncology USA Efforts to Promote Team-based Care and Regional Medical Collaboration for Cancer PatientsRelease Date:Partner: Japan Society of Clinical OncologyQuality Improvement Oncology Japan ISID-Pfizer 2021 Grant ChallengeRelease Date:Partner: The International Society for Infectious Diseases (ISID)Quality Improvement Hospital All Data generation on the treatment of Metastatic Breast Cancer with CDK 4/6 inhibitorsRelease Date:Research Oncology Portugal China Medical Education in Breast Cancer Diagnosis and TreatmentRelease Date:Education Oncology China Hemophilia: Improve Knowledge Level of Gene TherapyRelease Date:Education Rare Disease Japan Understanding Healthcare disparities in IBD Patients in Underserved CommunitiesRelease Date:Quality Improvement Inflammation & Immunology Canada, USA